HeartSciences Inc. (HSCS) - Form 8-K Summary
Business Context and Reporting Period
HeartSciences Inc., a Texas corporation, filed this Current Report on Form 8-K on September 16, 2025. The report addresses the status of the Company's listing on The Nasdaq Stock Market LLC, specifically regarding compliance with the Minimum Stockholders' Equity Requirement.
Key Financial Metrics
This filing does not contain specific financial statements, revenue, profit, cash flow, or debt figures. The only financial metric referenced is the regulatory threshold of $2.5 million in stockholders' equity required by Nasdaq Listing Rule 5550(b)(1).
Material Changes
On September 16, 2025, the Company received formal notice from Nasdaq indicating it has regained compliance with the Minimum Stockholders' Equity Requirement. This resolves a prior non-compliance issue disclosed on March 21, 2025, where the Company failed to meet the $2.5 million equity threshold or alternative listing standards. The matter is now closed.
Outlook and Management Commentary
Management previously submitted a specific plan to regain and sustain compliance, which was accepted by Nasdaq staff granting an extension of time. The successful resolution of this matter confirms the Company's continued eligibility for listing on The Nasdaq Capital Market. No new risks, contingencies, or unusual items are disclosed in this specific report.
Investor Verification Checklist
- Verify the Company's current stockholders' equity balance in the most recent quarterly or annual report to confirm it exceeds the $2.5 million threshold.
- Review the March 21, 2025 Form 8-K to understand the specific details of the prior non-compliance and the plan submitted to Nasdaq.
- Monitor future filings to ensure the Company maintains compliance with Nasdaq listing standards to avoid potential delisting risks.